Scott E. Eggener

18.9k total citations · 4 hit papers
242 papers, 9.4k citations indexed

About

Scott E. Eggener is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Rheumatology. According to data from OpenAlex, Scott E. Eggener has authored 242 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 176 papers in Pulmonary and Respiratory Medicine, 101 papers in Surgery and 48 papers in Rheumatology. Recurrent topics in Scott E. Eggener's work include Prostate Cancer Diagnosis and Treatment (108 papers), Prostate Cancer Treatment and Research (105 papers) and Urologic and reproductive health conditions (44 papers). Scott E. Eggener is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (108 papers), Prostate Cancer Treatment and Research (105 papers) and Urologic and reproductive health conditions (44 papers). Scott E. Eggener collaborates with scholars based in United States, Canada and United Kingdom. Scott E. Eggener's co-authors include Ofer Yossepowitch, James A. Eastham, Peter T. Scardino, Misop Han, Kimberly A. Roehl, William J. Catàlona, Paul Russo, Shilajit Kundu, Sergey Shikanov and Robert J. Motzer and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Scott E. Eggener

235 papers receiving 9.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy

2011 468 citations Scott E. Eggener, Peter T. Scardino et al. profile →
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management

2022 226 citations James A. Eastham, Scott E. Eggener et al. profile →
Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening

2023 172 citations Scott E. Eggener, Misop Han et al. profile →
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up

2022 124 citations James A. Eastham, Scott E. Eggener et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott E. Eggener United States	54	6.6k	3.2k	1.8k	1.5k	1.2k	242	9.4k
Andrew J. Stephenson United States	51	7.7k 1.2×	3.4k 1.0×	1.7k 1.0×	1.7k 1.2×	1.2k 1.0×	242	10.5k
Phillip M. Pierorazio United States	42	5.9k 0.9×	3.1k 0.9×	1.0k 0.6×	2.8k 1.9×	746 0.6×	291	7.9k
Maxwell V. Meng United States	48	4.4k 0.7×	2.8k 0.9×	737 0.4×	1.1k 0.8×	1.4k 1.2×	224	7.5k
Padraig Warde Canada	61	9.7k 1.5×	5.1k 1.6×	2.0k 1.1×	1.7k 1.2×	3.2k 2.7×	420	16.2k
Paul H. Lange United States	60	7.4k 1.1×	3.5k 1.1×	2.1k 1.2×	2.9k 1.9×	2.1k 1.8×	265	12.6k
Soroush Rais‐Bahrami United States	43	5.5k 0.8×	1.4k 0.4×	1.9k 1.1×	1.1k 0.8×	628 0.5×	288	7.5k
Filiberto Zattoni Italy	32	5.7k 0.9×	2.3k 0.7×	2.0k 1.2×	909 0.6×	910 0.8×	187	7.7k
Michael O. Koch United States	54	3.1k 0.5×	3.3k 1.0×	1.1k 0.6×	1.5k 1.1×	1.5k 1.3×	280	8.3k
Robert Huddart United Kingdom	62	5.6k 0.9×	7.8k 2.4×	1.2k 0.7×	2.7k 1.8×	3.2k 2.7×	388	14.9k
Thomas Wiegel Germany	38	8.2k 1.2×	1.9k 0.6×	1.6k 0.9×	838 0.6×	1.8k 1.6×	232	10.5k

Countries citing papers authored by Scott E. Eggener

Since Specialization

Citations

This map shows the geographic impact of Scott E. Eggener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott E. Eggener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott E. Eggener more than expected).

Fields of papers citing papers by Scott E. Eggener

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott E. Eggener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott E. Eggener. The network helps show where Scott E. Eggener may publish in the future.

Co-authorship network of co-authors of Scott E. Eggener

This figure shows the co-authorship network connecting the top 25 collaborators of Scott E. Eggener. A scholar is included among the top collaborators of Scott E. Eggener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott E. Eggener. Scott E. Eggener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morgan, Todd M., et al.. (2024). Prostate cancer and solid organ transplantation: Patient management and outcomes. European Urology. 85. S341–S341. 1 indexed citations

Ghoreifi, Alireza, Anirban P. Mitra, Jie Cai, et al.. (2022). Robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: A multicenter collaborative study. Urologic Oncology Seminars and Original Investigations. 41(2). 111.e7–111.e14. 6 indexed citations

Helenowski, Irene, Borko Jovanovic, Scott E. Eggener, et al.. (2022). Assessing the accuracy of multiparametric MRI to predict clinically significant prostate cancer in biopsy naïve men across racial/ethnic groups. BMC Urology. 22(1). 107–107. 3 indexed citations

Daneshmand, Siamak, Clint Cary, Timothy A. Masterson, et al.. (2021). SEMS trial: Result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma.. Journal of Clinical Oncology. 39(6_suppl). 375–375. 21 indexed citations

Chatterjee, Aritrick, Roger Bourne, Ambereen Yousuf, et al.. (2021). Validation of Prostate Tissue Composition by Using Hybrid Multidimensional MRI: Correlation with Histologic Findings. Radiology. 302(2). 368–377. 21 indexed citations

Wang, Shiyang, Aritrick Chatterjee, Milica Medved, et al.. (2020). T2*-weighted MRI as a non-contrast-enhanced method for assessment of focal laser ablation zone extent in prostate cancer thermotherapy. European Radiology. 31(1). 325–332. 3 indexed citations

Bhanvadia, Raj, et al.. (2019). Lymph node count impacts survival following post‐chemotherapy retroperitoneal lymphadenectomy for non‐seminomatous testicular cancer: a population‐based analysis. British Journal of Urology. 124(5). 792–800. 11 indexed citations

Dall’Era, Marc, et al.. (2018). Active surveillance for prostate cancer. Translational Andrology and Urology. 7(2). 195–196. 1 indexed citations

Packiam, Vignesh T., Charles U. Nottingham, Andrew J. Cohen, Scott E. Eggener, & Glenn S. Gerber. (2018). No Effect of Music on Anxiety and Pain During Transrectal Prostate Biopsies: A Randomized Trial. Urology. 117. 31–35. 25 indexed citations

10.

Tallman, Jacob E., Vignesh T. Packiam, Kristen Wroblewski, Gladell P. Paner, & Scott E. Eggener. (2017). Influence of pathologist experience on positive surgical margins following radical prostatectomy. Urologic Oncology Seminars and Original Investigations. 35(7). 461.e1–461.e6. 11 indexed citations

11.

Smith, Zachary L., Ryan P. Werntz, & Scott E. Eggener. (2017). Testicular Cancer. Medical Clinics of North America. 102(2). 251–264. 112 indexed citations

12.

Smid, Marcela C., et al.. (2014). Renal hemorrhagic actinomycotic abscess in pregnancy. Infectious Disease Reports. 6(1). 5157–5157. 4 indexed citations

13.

Loeb, Stacy, Christopher E. Bayne, Ben Davies, et al.. (2013). Use of social media in urology: data from the A merican U rological A ssociation ( AUA ). British Journal of Urology. 113(6). 993–998. 117 indexed citations

14.

Corbin, Kimberly S., Rangesh Kunnavakkam, Scott E. Eggener, & Stanley L. Liauw. (2012). Intensity modulated radiation therapy after radical prostatectomy: Early results show no decline in urinary continence, gastrointestinal, or sexual quality of life. Practical Radiation Oncology. 3(2). 138–144. 16 indexed citations

15.

Messer, Jamie, John D. Terrell, Michael Herman, et al.. (2011). Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma. Urologic Oncology Seminars and Original Investigations. 31(6). 904–908. 65 indexed citations

16.

Jayram, Gautam, et al.. (2011). Global Trends in Testicular Cancer Incidence and Mortality. European Urology. 60(2). 374–379. 103 indexed citations

17.

Stephenson, Andrew J., Michael W. Kattan, Eric A. Klein, et al.. (2009). POD-05.08: Predicting the Long-Term Risk of Prostate Cancer-Specific Mortality After Radical Prostatectomy. Urology. 74(4). S16–S16. 1 indexed citations

18.

Katz, Mark H. & Scott E. Eggener. (2009). The evolution, controversies, and potential pitfalls of modified retroperitoneal lymph node dissection templates. World Journal of Urology. 27(4). 477–483. 9 indexed citations

19.

Large, Michael C., Joel Sheinfeld, & Scott E. Eggener. (2009). Retroperitoneal lymph node dissection: reassessment of modified templates. British Journal of Urology. 104(9b). 1369–1375. 18 indexed citations

20.

Shikanov, Sergey, Scott E. Eggener, Mark H. Katz, et al.. (2008). Robotic Radical Prostatectomy in Overweight and Obese Patients: Oncological and Validated-Functional Outcomes. Urology. 73(2). 316–322. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact